BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38364701)

  • 1. Genomic characteristics and immune landscape of super multiple primary lung cancer.
    Yang Z; Zhou B; Guo W; Peng Y; Tian H; Xu J; Wang S; Chen X; Hu B; Liu C; Wang Z; Li C; Gao S; He J
    EBioMedicine; 2024 Mar; 101():105019. PubMed ID: 38364701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic and transcriptomic significance of multiple primary lung cancers detected by next-generation sequencing in clinical settings.
    Yao M; Chen H; Chen Z; Wang Y; Shi D; Wu D; Li W; Huang J; Chen G; Zheng Q; Ye Z; Zheng C; Yang Y
    Carcinogenesis; 2024 Jun; 45(6):387-398. PubMed ID: 38693810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and immune characteristics of multiple primary lung cancers and lung metastases.
    Yang R; Li P; Wang D; Wang L; Yin J; Yu B; Li M; Wang S; Wang Y
    Thorac Cancer; 2021 Oct; 12(19):2544-2550. PubMed ID: 34510768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lineage tracing for multiple lung cancer by spatiotemporal heterogeneity using a multi-omics analysis method integrating genomic, transcriptomic, and immune-related features.
    Song Y; Zhou J; Zhao X; Zhang Y; Xu X; Zhang D; Pang J; Bao H; Ji Y; Zhan M; Wang Y; Ou Q; Hu J
    Front Oncol; 2023; 13():1237308. PubMed ID: 37799479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Identification and Genetic Characterization of Early-Stage Multiple Primary Lung Cancer by Large-Panel Next-Generation Sequencing Analysis.
    Pei G; Li M; Min X; Liu Q; Li D; Yang Y; Wang S; Wang X; Wang H; Cheng H; Cao S; Huang Y
    Front Oncol; 2021; 11():653988. PubMed ID: 34109114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis.
    Tian H; Wang Y; Yang Z; Chen P; Xu J; Tian Y; Fan T; Xiao C; Bai G; Li L; Zheng B; Li C; He J
    Cancer Gene Ther; 2023 Mar; 30(3):507-520. PubMed ID: 36653483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic characteristics of early-stage multiple primary and independent primary lung adenocarcinoma patients.
    Li P; Yang R; Wang D; Wang L; Wang S; Liu C; Li J; Li L; Liu C; Tong Y; Wang Y
    Asia Pac J Clin Oncol; 2022 Oct; 18(5):e420-e426. PubMed ID: 35098658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
    Hu C; Zhao L; Liu W; Fan S; Liu J; Liu Y; Liu X; Shu L; Liu X; Liu P; Deng C; Qiu Z; Chen C; Jiang Y; Liang Q; Yang L; Shao Y; He Q; Yu D; Zeng Y; Li Y; Pan Y; Zhang S; Shi S; Peng Y; Wu F
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell RNA sequencing analysis reveals transcriptional heterogeneity of multiple primary lung cancer.
    Guo W; Zhou B; Bie F; Huai Q; Xue X; Guo L; Tan F; Xue Q; Zhao L; Gao S
    Clin Transl Med; 2023 Oct; 13(10):e1453. PubMed ID: 37846760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple primary lung cancer: Updates of clinical management and genomic features.
    Tian H; Bai G; Yang Z; Chen P; Xu J; Liu T; Fan T; Wang B; Xiao C; Li C; Gao S; He J
    Front Oncol; 2023; 13():1034752. PubMed ID: 36910635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using molecular characteristics to distinguish multiple primary lung cancers and intrapulmonary metastases.
    Li Z; Lv H; Zhang F; Zhu Z; Guo Q; Wang M; Huang C; Guo L; Meng F; Tian Z
    PeerJ; 2024; 12():e16808. PubMed ID: 38313018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of Criteria for Molecular Differential Diagnosis of MPLC and IPM.
    Wang X; Gong Y; Yao J; Chen Y; Li Y; Zeng Z; Lu Y; Song L
    Front Oncol; 2020; 10():614430. PubMed ID: 33552986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients.
    Liang Z; Zeng G; Wan W; Deng B; Chen C; Li F; Lin G; Lin Y; Lin H; Mo G; Miao H
    Discov Med; 2023 Apr; 35(175):131-143. PubMed ID: 37188510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characteristics of multiple primary pulmonary nodules under a three-dimensional reconstruction model and relevant multi-omics analyses: a case report.
    Luo Z; Xiao Y; Luo C; Zhang L; Zhou R; Zhao Z; Sun C; Wu D; Wang T
    Front Oncol; 2023; 13():1064475. PubMed ID: 37205198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of multiple primary lung cancer in patients with multifocal lung cancer: assessment of a machine learning approach using multidimensional genomic data.
    Pei G; Sun K; Yang Y; Wang S; Li M; Ma X; Wang H; Chen L; Qin J; Cao S; Liu J; Huang Y
    Front Oncol; 2024; 14():1388575. PubMed ID: 38764572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of
    Li C; Wang Y; Su K; Liu Y; Wang L; Zheng B; Yan N; Yuan D; Zhang Y; Xue L; Gao S; He J
    Transl Lung Cancer Res; 2021 Apr; 10(4):1734-1746. PubMed ID: 34012789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
    Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
    J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genomic mutational landscape and its correlation with TMB, PD-L1 expression and CD8
    Li Y; Shi X; Mao B; Wang L; Wu L; Li J; Jiao S
    Lung Cancer; 2022 Apr; 166():161-169. PubMed ID: 35287068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of atypical adenomatous hyperplasia, minimally invasive adenocarcinoma and invasive adenocarcinoma: Gene mutation analysis.
    Song J; Xu Y; Yang Z; Liu Y; Zhang P; Wang X; Sun C; Guo Y; Qiu S; Shao G; Ma K
    Thorac Cancer; 2021 Mar; 12(5):693-698. PubMed ID: 33442956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer.
    Shi Y; Lei Y; Liu L; Zhang S; Wang W; Zhao J; Zhao S; Dong X; Yao M; Wang K; Zhou Q
    Cancer Med; 2021 Apr; 10(7):2216-2231. PubMed ID: 33655698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.